Русский
Anemia in adult cancer patients
DOI: https://dx.doi.org/10.18565/pharmateca.2023.6-7.101-109
G.M. Teletaeva, E.A. Degtiareva, S.A. Protsenko, D.Kh. Latipova, A.I. Semenova, A.V. Novik, T.Yu. Semiglazova
N.N. Petrov National Medical Research Center of Oncology, St. Petersburg, Russia
Anemia is a frequent complication of the malignant process, negatively affecting the quality of life of the patient, as well as the results of anticancer treatment and the prognosis of the disease in general. The pathogenesis of anemia in a malignant process is quite complex and is attributable both to the presence of the tumor itself and to the ongoing antitumor treatment. This review summarizes current ideas about the causes and mechanisms of anemia in cancer patients, discusses the diagnostic algorithm and key methods for correcting this condition.
Keywords: chemotherapy-induced anemia, cancer-related anemia, blood transfusions, erythropoietins, anemia of chronic diseases, iron preparations
About the Autors
Corresponding author: Gulfiya M. Teletaeva, Cand. Sci. (Med.), Oncologist, Department of Antitumor Drug Therapy, N.N. Petrov National Medical Research Center of Oncology, St. Petersburg, Russia; drteletaeva@yahoo.com
Similar Articles
